Filetype
The focus of the research performed at the department involves various aspects of Immuno-oncology, Biomarkers and Sensitisation. These research areas represent an exceedingly developing field of biomedicine, which holds great promises for future possibilities for important areas of disease, such as cancer and allergy.The research focus is supported by a framework of vital, in-house technology plat
https://www.immun.lth.se/research - 2026-10-03
https://www.ctg.lu.se/services/single-cell - 2026-10-03
Microscopy analysis of tumour samples is commonly performed on fixed, thinly sectioned and protein-labelled tissues. However, these examinations do not reveal the intricate three-dimensional structures of tumours, nor enable the detection of aberrant transcripts. Here, we report a method, which we name DIIFCO (for diagnosing in situ immunofluorescence-labelled cleared oncosamples), for the multimo
Lund University research projects Currently at Lund Univeristy, ten research projects are driven by ten Principle Investigators from the Faculty of Engineering (LTH) and the Faculty of Medicine. The common goal of all of them is to deepen knowledge and fast forward innovations in cancer diagnostics and treatment. Molecular characterisation of breast cancer: biomarkers of risk, prognosis and treatm
https://www.createhealth.lth.se/research/research-projects - 2026-10-03
Mycosis fungoides (MF) and Sézary syndrome (SS) are two closely related clinical variants of cutaneous T-cell lymphomas (CTCL). Previously demonstrated large patient-to-patient and intra-patient disease heterogeneity underpins the importance of personalized medicine in CTCL. Advanced stages of CTCL are characterized by dismal prognosis, and the early identification of patients who will progress re
The incidence of oropharyngeal cancer (OPC) is increasing in developed countries, and OPC is associated with human papillomavirus infection [1, 2]. Immunotherapies show promise as an end-stage treatment for immune-infiltrated tumours. They are only efficacious in 18% of patients leading to investigation of the immune compartment to comprehend which factors contribute to effective treatments. Anti-
The Swedish Network for European Studies in Economics and Business (SNEE) is commissioned by the Swedish government, and run by Lund University through the School of Economics and Management.Our goal is to gather researchers at Swedish universities who work with European research from an economic perspective. To achieve this, we arrange annual research conferences on European integration that brin
Bladder cancer is the ninth most common type of cancer globally, and the projected number of deaths is estimated to almost double by the year 2040. Immunotherapy with checkpoint inhibitors has revolutionized treatment of bladder cancer and can achieve durable responses; however, only a minority of patients respond. By identifying additional targets and treatment combinations, more patients could b
WCMM Lund Celebrates 10 Years of Research Excellence! This year marks the 10-year anniversary of WCMM Lund — a decade of pioneering research, collaboration, and scientific breakthroughs. It's an excellent opportunity to highlight the progress we've made, the impactful work carried out by our researchers, and the many success stories that have shaped our community. To celebrate this milestone, we’r
https://www.wcmm.lu.se/whats/wcmm-10-year-anniversary-conference - 2026-10-03
